[go: up one dir, main page]

WO2008133206A1 - Non-replicating paramyxoviridae virus vector - Google Patents

Non-replicating paramyxoviridae virus vector Download PDF

Info

Publication number
WO2008133206A1
WO2008133206A1 PCT/JP2008/057609 JP2008057609W WO2008133206A1 WO 2008133206 A1 WO2008133206 A1 WO 2008133206A1 JP 2008057609 W JP2008057609 W JP 2008057609W WO 2008133206 A1 WO2008133206 A1 WO 2008133206A1
Authority
WO
WIPO (PCT)
Prior art keywords
gene
vector
replicating
sev
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2008/057609
Other languages
French (fr)
Japanese (ja)
Inventor
Makoto Inoue
Hiroshi Ban
Mamoru Hasegawa
Yutaka Hanazono
Yukiko Kishi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jichi Medical University
Dnavec Corp
Original Assignee
Jichi Medical University
Dnavec Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jichi Medical University, Dnavec Corp filed Critical Jichi Medical University
Publication of WO2008133206A1 publication Critical patent/WO2008133206A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/60—Fusion polypeptide containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18811—Sendai virus
    • C12N2760/18851—Methods of production or purification of viral material
    • C12N2760/18852—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

A non-replicating SeV vector (SeV/ΔP vector) can be successfully produced, which has the deletion of a gene for P-protein that is a protein constituting an RNP from genomic RNA or the inactivation of the gene. It is found that an SeV vector which has the deletion or inactivation of P gene and carries a marker gene such as a gene for GFP or luciferase can be used for achieving a high transfer efficiency of a foreign gene into a cell or a high expression efficiency of a foreign gene in a cell. It is also found that the vector has reduced cytotoxicity, because P gene is deleted or inactivated in the vector to cause the reduction of the amount of a virus-derived protein expressed in a host cell.
PCT/JP2008/057609 2007-04-19 2008-04-18 Non-replicating paramyxoviridae virus vector Ceased WO2008133206A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2007110547 2007-04-19
JP2007-110547 2007-04-19
JP2007-127421 2007-05-11
JP2007127421 2007-05-11

Publications (1)

Publication Number Publication Date
WO2008133206A1 true WO2008133206A1 (en) 2008-11-06

Family

ID=39925660

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/057609 Ceased WO2008133206A1 (en) 2007-04-19 2008-04-18 Non-replicating paramyxoviridae virus vector

Country Status (1)

Country Link
WO (1) WO2008133206A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010008054A1 (en) * 2008-07-16 2010-01-21 ディナベック株式会社 Method for production of reprogrammed cell using chromosomally unintegrated virus vector
WO2016125364A1 (en) * 2015-02-02 2016-08-11 株式会社Ｉｄファーマ Improved negative-strand rna viral vector
US12252700B2 (en) 2015-11-13 2025-03-18 Id Pharma Co., Ltd. Paramyxovirus vector

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005065596A (en) * 2003-08-25 2005-03-17 Japan Science & Technology Agency Proliferative ability deficient rabies virus
WO2007007921A1 (en) * 2005-07-13 2007-01-18 Kyushu University, National University Corporation Segmented genome type recombinant mononegavirus vector

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005065596A (en) * 2003-08-25 2005-03-17 Japan Science & Technology Agency Proliferative ability deficient rabies virus
WO2007007921A1 (en) * 2005-07-13 2007-01-18 Kyushu University, National University Corporation Segmented genome type recombinant mononegavirus vector

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
HANAZONO Y.: "Shinki Sendai Virus Vector o Mochiita Saitaiketsu Kansaibo Zofukuho no Kaihatsu", SHINKI SENDAI VIRUS VECTOR O MOCHIITA SAITAIKETSU KANSAIBO ZOFUKUHO NO KAIHATSU HEISEI 18 NENDO SOKATSU. BUNTAN KENKYU HOKOKUSHO, March 2007 (2007-03-01), pages 1 - 7 *
INOUE M.: "HoxB4 Idenshi o Tosao suru P Kessongata SeV Vector no Sakusei to Seino Hyoka ni Kansuru Kenkyu", SHINKI SENDAI VIRUS VECTOR O MOCHIITA SAITAIKETSU KANSAIBO ZOFUKUHO NO KAIHATSU HEISEI 18 NENDO SOKATSU. BUNTAN KENKYU HOKOKUSHO, March 2007 (2007-03-01), pages 8 - 11 *
MORIMOTO K.: "Virus Vector o Oyo shita Vaccine Kaihatsu Jinsokuka no Tameno Kibanteki Gijutsu Kaihatsu no Kenkyu", VIRUS VECTOR O OYO SHITA VACCINE KAIHATSU JINSOKUKA NO TAMENO KIBANTEKI GIJUTSU KAIHATSU NO KENKYU HEISEI 17 NENDO SOKATSU. BUNTAN KENKYU HOKOKUSHO, 2006, pages 1 - 15 *
WIEGAND M.A. ET AL.: "De novo synthesis of N and P proteins as a key step in Sendai virus gene expression", J. VIROL., vol. 81, no. 24, pages 13835 - 13844, XP002684869, DOI: doi:10.1128/JVI.00914-07 *

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010008054A1 (en) * 2008-07-16 2010-01-21 ディナベック株式会社 Method for production of reprogrammed cell using chromosomally unintegrated virus vector
US9127256B2 (en) 2008-07-16 2015-09-08 Dnavec Corporation Method for production of reprogrammed cell using chromosomally unintegrated virus vector
US9695445B2 (en) 2008-07-16 2017-07-04 Id Pharma Co., Ltd. Method for production of reprogrammed cell using chromosomally unintegrated virus vector
US11136594B2 (en) 2008-07-16 2021-10-05 Id Pharma Co., Ltd. Method for production of reprogrammed cell using chromosomally unintegrated virus vector
WO2016125364A1 (en) * 2015-02-02 2016-08-11 株式会社Ｉｄファーマ Improved negative-strand rna viral vector
JPWO2016125364A1 (en) * 2015-02-02 2017-11-30 株式会社Ｉｄファーマ Improved minus-strand RNA viral vector
JP2020195381A (en) * 2015-02-02 2020-12-10 株式会社Ｉｄファーマ Improved negative-strand RNA virus vector
US12252700B2 (en) 2015-11-13 2025-03-18 Id Pharma Co., Ltd. Paramyxovirus vector

Similar Documents

Publication Publication Date Title
WO2022221359A8 (en) Epstein-barr virus mrna vaccines
CA2860388C (en) Parainfluenza virus 5 based vaccines
WO2011015656A3 (en) Composition for treating hbv infection
AU2016262093A8 (en) Enhancing endonuclease based gene editing in primary cells
WO2003091401A3 (en) Multi plasmid system for the production of influenza virus
EP4484556A3 (en) Compositions of and methods for in vitro viral genome engineering
WO2011082388A3 (en) Infectious dna vaccines against chikungunya virus
HRP20211015T1 (en) Cmv vaccines
WO2010102257A3 (en) Methods for cloning and manipulating genomes
WO2007002008A3 (en) Methods and compositions for expressing negative-sense viral rna in canine cells
AU2007240448A8 (en) Methods and compositions for expressing negative-sense viral RNA in canine cells
CL2012000452A1 (en) Infectious nucleic acid of porcine torque virus (pttv), comprising sequence encoding an infectious pttv with a genomic sequence of pttv 1a-va; nucleic acid, plasmid and host cell comprising it; non-virulent infectious pttv; vaccine.
WO2011033375A3 (en) Products and methods for enhanced transgene expression and processing
WO2011048353A3 (en) Construct for production of empty picornaviral capsids
WO2008028661A3 (en) Potexvirus- derived replicon
WO2011072247A3 (en) Pathogen restriction factors
WO2008148104A8 (en) Novel vlps derived from cells that do not express a viral matrix or core protein
UA108902C2 (en) NORTH AMERICAN REPRODUCTIVE AND RESPIRATORY PIG SYNDROME (PRRS) VIRUS
PH12015500499A1 (en) Recombinant measles virus expressing chikungunya virus polypeptides and their applications
WO2010118188A3 (en) Production of an intact virus in a non-host cell system using a secondary host viral construct
ECSP10010375A (en) DAMAGED ONCOLITICAL PARAMIXOVIRUS THAT CODIFY BIRD CYTOKINS
DK2431470T3 (en) DNase expression in recombinant host cells
WO2010118205A3 (en) Production of an intact virus in a mammalian (non-host) cell system using a secondary non-host viral construct
WO2007047459A8 (en) Rabies virus vector systems and compositions and methods thereof
CN104195154B (en) Avian pneumo-encephalitis virus Mukteswar mesogenic vaccine strain reverse genetic operating system and application thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08751879

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08751879

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: JP